NCT05722197 Assessment of Emotion Regulation Strategies Used When Suicidal
| NCT ID | NCT05722197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Suicidal Ideation |
| Study Type | INTERVENTIONAL |
| Enrollment | 334 participants |
| Start Date | 2022-01-23 |
| Primary Completion | 2027-01-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 334 participants in total. It began in 2022-01-23 with a primary completion date of 2027-01-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Crisis Response Planning is an efficacious, one-session intervention that increases positive affect, decreases negative affect and psychiatric hospitalizations, and reduces suicide attempts by 76% among Servicemembers. Crisis Response Planning is hypothesized to reduce suicidality by identifying a variety of personalized strategies that are designed to strengthen and/or promote emotion regulation processes.Research in nonmilitary samples suggests the effectiveness of emotion regulation strategies varies across situations. The applicability of these findings to suicidality among Servicemembers is unknown. Improved understanding of what strategies work under which circumstances and for whom will significantly advance our ability to prevent suicide among Servicemembers. Hypotheses include: 1. Use of self-management strategies, thinking about reasons for living, and seeking social support at time t will be associated with significant reductions in suicidal ideation at time t+1. 2. Use of distraction, reappraisal, and interpersonal emotion regulation strategies at time t will be associated with significant reductions in suicidal ideation at time t+1. 3. Affect intensity and social context will significantly moderate the time-lagged effects of Crisis Response Planning and emotion regulation strategy use on suicidal ideation. 4. Distinct profiles of demographic (e.g., gender, age), historical (e.g., prior suicide attempts), and psychological characteristics (e.g., emotion dysregulation, symptom severity) will predict who experiences a decrease in suicidal ideation following the use of Crisis Response Planning and emotion regulation strategies. 5. (Exploratory): Individuals who utilize their Crisis Response Planning more frequently and perceive Crisis Response Planning as more effective will be more likely to engage in mental health treatment at follow-up.
Eligibility Criteria
Inclusion Criteria: * Currently serving in any Branch or Component of the U.S. military * \>18 years old; * Score ≥ 5 on the Scale for Suicidal Ideation and/or endorse a suicide attempt, aborted attempt, or interrupted attempt within the past month on the Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R) * Ability and willingness to complete research-related activities remotely * Regular access to an Android or Apple smartphone that is compatible with the ecological momentary assessment application Exclusion Criteria: * Engagement in mental health treatment within the past year (including taking psychotropic medications) * A psychiatric or medical condition that preventing providing informed consent or from participating in the treatments (e.g., psychosis, mania, acute intoxication); or - Expecting to separate from the military within 90 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05722197 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05722197 currently recruiting?
Yes, NCT05722197 is actively recruiting participants. Contact the research team at lauren.khazem@osumc.edu for enrollment information.
Where is the NCT05722197 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT05722197 clinical trial?
NCT05722197 is sponsored by Ohio State University. The trial plans to enroll 334 participants.